Showing results (51-60 of 69) with videos related to
Sort By:
Pageof 7
Cell Death & Disease|December 6, 2023
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cellsMelina Vogt, Niklas Dienstbier, Julian Schliehe-Diecks, et al.Cancer Research|March 2, 2018
Loss of Pax5 Exploits Sca1-BCR-ABL<sup>p190</sup> Susceptibility to Confer the Metabolic Shift Essential for pB-ALLAlberto Martín-Lorenzo, Franziska Auer, Lai N Chan, et al.Cancer Discovery|September 27, 2015
Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited SusceptibilityAlberto Martín-Lorenzo, Julia Hauer, Carolina Vicente-Dueñas, et al.ACS Central Science|June 1, 2022
Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 DimerizationSanil Bhatia, Lukas Spanier, David Bickel, et al.Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 6, 2024
[Early Detection Of Type 1 Diabetes By Islet Autoantibody Screening: A Position Paper Of The Fr1daplex Project Leaders And Training Centres, Bvkj Bavaria And Paednetz (Registered) Bavaria]Peter Achenbach, Reinhard Berner, Ezio Bonifacio, et al.Blood Advances|January 6, 2023
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from GermanyPeter Bader, Claudia Rossig, Martin Hutter, et al.Blood|September 10, 2020
An intact gut microbiome protects genetically predisposed mice against leukemiaCarolina Vicente-Dueñas, Stefan Janssen, Marina Oldenburg, et al.EMBO Molecular Medicine|March 14, 2025
Immune training enhances anti-viral responses and improves outcomes in Pax5<sup>-/+</sup> mice susceptible to chronic infectionZhe Lu, Olivia Stencel, Wei Liu, et al.The Journal of Clinical Investigation|August 9, 2008
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1Salima Hacein-Bey-Abina, Alexandrine Garrigue, Gary P Wang, et al.International Journal of Molecular Sciences|May 14, 2022
Recurrent Germline Variant in <i>RAD21</i> Predisposes Children to Lymphoblastic Leukemia or LymphomaAnne Schedel, Ulrike Anne Friedrich, Mina N F Morcos, et al.Pageof 7